|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
British Columbia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing British ColumbiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
DelMar Pharmaceuticals, Inc.
| | | Phone: | (604) 629-5989 | Fax: | (604) 608-5685 | Year Established: | 2010 | Ticker: | DMPI | Exchange: | OTCQX® | Main Contact: | Saiid Zarrabian, Initerim President & CEO | | Other Contacts: | Scott Praill, CA, CFO Dennis M. Brown, Ph.D., CSO & Co-Founder
| | Company Description | DelMar Pharmaceuticals is focused on the development and commercialization of new therapies for cancer patients who have limited or no treatment options. By developing an understanding of tumor biology and mechanisms of treatment resistance, the Company identifies biomarkers to personalize new therapies in indications where patients are failing, or have become intolerable to modern targeted or biologic treatments. | |
|
|
|
|
|